推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 據(jù)巴斯夫1月26日發(fā)布消息顯示，巴斯夫擴(kuò)大其維生素A工廠產(chǎn)能25%。該工廠位于德國路德維希港，是檸檬醛一體化(Verbund)的一部分。通過擴(kuò)產(chǎn)，巴斯夫可以更好滿足高品質(zhì)維生素A市場需求的增長，也可以滿足不斷增長的全球市場需求。新增的產(chǎn)能可以很快投產(chǎn)?！ ?/p>
由于維生素A的技術(shù)門檻較高，目前國內(nèi)僅有新和成、浙江醫(yī)藥和廈門金達(dá)威能實現(xiàn)規(guī)模化生產(chǎn)，這3家企業(yè)的維生素A產(chǎn)能合計約占全球市場份額的40%。國際生產(chǎn)企業(yè)有帝斯曼、巴斯夫、安迪蘇，3家企業(yè)占了全球市場份額的60%。生產(chǎn)維生素A的關(guān)鍵性原材料檸檬醛(或者b-紫羅蘭酮)的來源長期以來是限制企業(yè)維生素A產(chǎn)業(yè)發(fā)展和生產(chǎn)成本的關(guān)鍵因素之一。從目前產(chǎn)業(yè)發(fā)展變化看，或許上游技術(shù)和市場格局的變化會對維生素A格局帶來影響。
1月26日維生素A商品指數(shù)為96.32，較昨日下降了0.39點，較周期內(nèi)最高點136.24點(2014-06-08)下降了29.30%，較2013年03月10日最低點88.79點上漲了8.48%。(注：周期指2012-03-01至今)
